Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Cancer
|
November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer
Emily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.
American Journal of Obstetrics and Gynecology
|
August 18, 2020
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer
Shannon N Westin, Bryan Fellman, Charlotte C Sun, et al.
Molecular Cancer Therapeutics
|
April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers
Ji Son, Yingao Zhang, Heather Lin, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States
Ryan A Denu, Zhao Zheng, Yingda Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2021
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
Shannon N Westin, Marilyne Labrie, Jennifer K Litton, et al.
Nature
|
July 3, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapy
Yibo Dai, Anne Knisely, Mitsutake Yano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2025
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunities
Anne Knisely, Yibo Dai, Graham L Barlow, et al.
Gynecologic Oncology
|
August 21, 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
Koji Matsuo, James C Cripe, Katherine C Kurnit, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Cancer
|
November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer
Emily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.
American Journal of Obstetrics and Gynecology
|
August 18, 2020
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer
Shannon N Westin, Bryan Fellman, Charlotte C Sun, et al.
Molecular Cancer Therapeutics
|
April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers
Ji Son, Yingao Zhang, Heather Lin, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States
Ryan A Denu, Zhao Zheng, Yingda Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2021
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
Shannon N Westin, Marilyne Labrie, Jennifer K Litton, et al.
Nature
|
July 3, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapy
Yibo Dai, Anne Knisely, Mitsutake Yano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2025
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunities
Anne Knisely, Yibo Dai, Graham L Barlow, et al.
Gynecologic Oncology
|
August 21, 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
Koji Matsuo, James C Cripe, Katherine C Kurnit, et al.
Page
of 15